Marker Therapeutics Inc (MRKR)

[MarkerMan]

Production. Manufacturing facility is center to the press release. POLYSTART and Zelenoleucel are results of a branding initiative. Branding occurs when there is a product to sell. Here is a partial description of their Kite hire “Nadia Agopyan joined Marker in August 2019 from Kite Pharma, a subsidiary of Gilead Sciences, where she served as Director of Regulatory Affairs, Global Regulatory Lead. In this role, she was responsible for overseeing the global marketing authorization.” While the FDA delay has been in focus management took paths with less resistance. Space of that magnitude is not taken hoping for growth or a way to pay for it.